Traceability
Distribution and inventory processes are intended to support product identification and lot-level traceability throughout our distribution operations.
Human tissue products require care at every stage, from donor screening and processing through packaging, storage, distribution and delivery. Evologics takes that responsibility seriously.
Quality depends on a series of documented processes and responsible organizations working together throughout the product lifecycle. Evologics evaluates products and partners with attention to product quality, regulatory status, tissue processing practices, documentation, storage requirements, traceability and distribution.
Human cells, tissues and cellular and tissue-based products, commonly referred to as HCT/Ps, are regulated by the U.S. Food and Drug Administration under frameworks that depend on the characteristics and intended use of the individual product.
Regulatory information is communicated by Evologics on a product-specific basis. FDA registration or product listing does not mean that a product has been approved, cleared, certified or endorsed by the FDA.
Evologics is currently completing the AATB accreditation process.
Distribution and inventory processes are intended to support product identification and lot-level traceability throughout our distribution operations.
Distribution processes are designed around the requirements established for each product, including appropriate storage conditions, inventory controls and shipping procedures.
Product characteristics and clinical descriptions should remain consistent with the regulatory pathway, labeling and evidence applicable to the specific product.
Healthcare partners may contact Evologics for available product-specific regulatory, quality, processing, storage and handling documentation.